Apyx Medical Corp. (NASDAQ: APYX) reported Q3 EPS of ($0.11), $0.05 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $7 million versus the consensus estimate of $5.68 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.